Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Remington

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Psychopharmacology|March 29, 2001
Awareness of tardive dyskinesia in Asian patients with schizophreniaS A Chong, G Remington, R Mahendran, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Healthcare resource utilization during 1-year treatment with long-acting, injectable risperidoneA Leal, D Rosillon, A Mehnert, et al.
Molecular Psychiatry|March 29, 2002
Significant dissociation of brain and plasma kinetics with antipsychoticsJohannes Tauscher, C Jones, G Remington, et al.
Journal of Comparative and Physiological Psychology|April 1, 1979
Escape performance after inescapable shock in selectively bred lines of mice: response maintenance and catecholamine activityH Anisman, L Grimmer, J Irwin, et al.
Psychopharmacology|May 2, 2000
Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levelsP B Fitzgerald, S Kapur, G Remington, et al.
Schizophrenia Research|October 20, 2009
Motivational deficits as the central link to functioning in schizophrenia: a pilot studyG Foussias, S Mann, K K Zakzanis, et al.
The American Journal of Psychiatry|November 14, 1997
PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophreniaS Kapur, R Zipursky, G Remington, et al.
Life Sciences|January 1, 1995
The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET studyS Kapur, G Remington, R B Zipursky, et al.
Clinical Therapeutics|September 1, 1993
Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective studyD E Addington, B Jones, D Bloom, et al.
Archives of General Psychiatry|June 6, 2000
A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancyS Kapur, R Zipursky, C Jones, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Psychopharmacology|March 29, 2001
Awareness of tardive dyskinesia in Asian patients with schizophreniaS A Chong, G Remington, R Mahendran, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Healthcare resource utilization during 1-year treatment with long-acting, injectable risperidoneA Leal, D Rosillon, A Mehnert, et al.
Molecular Psychiatry|March 29, 2002
Significant dissociation of brain and plasma kinetics with antipsychoticsJohannes Tauscher, C Jones, G Remington, et al.
Journal of Comparative and Physiological Psychology|April 1, 1979
Escape performance after inescapable shock in selectively bred lines of mice: response maintenance and catecholamine activityH Anisman, L Grimmer, J Irwin, et al.
Psychopharmacology|May 2, 2000
Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levelsP B Fitzgerald, S Kapur, G Remington, et al.
Schizophrenia Research|October 20, 2009
Motivational deficits as the central link to functioning in schizophrenia: a pilot studyG Foussias, S Mann, K K Zakzanis, et al.
The American Journal of Psychiatry|November 14, 1997
PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophreniaS Kapur, R Zipursky, G Remington, et al.
Life Sciences|January 1, 1995
The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET studyS Kapur, G Remington, R B Zipursky, et al.
Clinical Therapeutics|September 1, 1993
Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective studyD E Addington, B Jones, D Bloom, et al.
Archives of General Psychiatry|June 6, 2000
A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancyS Kapur, R Zipursky, C Jones, et al.
Pageof 10